ORIGINAL RESEARCH article
Front. Public Health
Sec. Infectious Diseases: Epidemiology and Prevention
Volume 13 - 2025 | doi: 10.3389/fpubh.2025.1454044
This article is part of the Research TopicWorld Hepatitis Day 2024: Advancing Hepatitis Elimination, Public Health Strategies and InnovationsView all 16 articles
Seroprevalence and Associated Factors of Hepatitis B Virus Among Diabetic Adult Patients Attending at Haramaya General Hospital, Eastern Ethiopia
Provisionally accepted- 1School of Medical Laboratory Sciences, College of Health and Medical Sciences, Haramaya University, Dire Dawa, Dire Dawa, Ethiopia
- 2Haramaya General Hospital, HARAMAYA, Ethiopia
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Hepatitis B virus (HBV) infection and diabetes mellitus are both significant public health concerns that substantially impact global morbidity and death. However, there is currently limited information available on the prevalence of HBV infection among diabetic patients in eastern Ethiopia. Therefore, this study aimed to determine the seroprevalence and associated factors of the hepatitis B virus among diabetic adult patients at Haramaya General Hospital in Eastern Ethiopia from August 8 to August 30, 2021.Methods: An institution-based cross-sectional study was done among 365 diabetic patients.Study participants were chosen using a consecutive sampling technique. Data on sociodemographic characteristics and other associated factors were collected using a structured questionnaire. A blood sample was drawn from each participant, and the serum was separated and tested for HBsAg status using the Rapid Test Kit (ACON, USA). The data was entered into Epi Data version 4.6 software and analysed using SPSS version 25. Bivariate and multivariable logistic regression analyses were performed to examine the association between the outcome variable and predictor factors. A p-value less than 0.05 was considered statistically significant.Results: A total of 365 individuals with diabetes took part in this study. The overall seroprevalence of hepatitis B surface antigen among these patients was 7.4% (95% CI = 4.71-10.08). Among the total of 365, about 243 individuals (66.3%) were male, and the participants had a mean age of 42.24±10.2 years. The only significant risk factor for hepatitis B virus (HBV) coinfection among the diabetic patients was having multiple sexual partners [AOR = 2.92, 95% CI: 1.2-7.08].among people with diabetes. Multiple sexual partners were strongly associated with an increased likelihood of HBV infection. Based on these findings, it is recommended to implement routine HBsAg screening for diabetic patients during regular medical visits to enable earlier detection and timely treatment. The government also should increase vaccination coverage for diabetic patients. Healthcare facilities, regional authorities, and experts should also teach diabetes patients about hepatitis B transmission routes and prevention strategies, with an emphasis on modifiable variables.
Keywords: Hepatitis B virus infection, seroprevalence, Diabetic mellitus, Hepatitis B screening, Eastern Ethiopia
Received: 24 Jun 2024; Accepted: 17 Apr 2025.
Copyright: © 2025 Ayele, Abdi, Mohammed and Ayana. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Firayad Ayele, School of Medical Laboratory Sciences, College of Health and Medical Sciences, Haramaya University, Dire Dawa, Dire Dawa, Ethiopia
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.